217 related articles for article (PubMed ID: 36291951)
1. Stereotactic Body Radiotherapy Boost with the CyberKnife for Locally Advanced Cervical Cancer: Dosimetric Analysis and Potential Clinical Benefits.
Gao J; Xu B; Lin Y; Xu Z; Huang M; Li X; Wu X; Chen Y
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291951
[TBL] [Abstract][Full Text] [Related]
2. Boost modalities in cervical cancer: dosimetric comparison between intracavitary BT vs. intracavitary + interstitial BT vs. SBRT.
Benkhaled S; Diakité K; Jullian N; Poeta S; Vandekerkhove C; Van Houtte P; Van Gestel D; De Caluwé A
Radiat Oncol; 2023 Jun; 18(1):105. PubMed ID: 37381016
[TBL] [Abstract][Full Text] [Related]
3. Assessment of HDR brachytherapy-replicating prostate radiotherapy planning for tomotherapy, cyberknife and VMAT.
de Chavez R; Grogan G; Hug B; Howe K; Grigg A; Waterhouse D; Lane J; Glyde A; Brown E; Bydder S; Pryor D; Hargrave C; Charles PH; Hellyer J; Ebert MA
Med Dosim; 2022 Spring; 47(1):61-69. PubMed ID: 34551879
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric comparison of stereotactic MR-guided radiation therapy (SMART) and HDR brachytherapy boost in cervical cancer.
Dincer N; Ugurluer G; Mustafayev TZ; Serkizyan A; Aydin G; Güngör G; Yapici B; Atalar B; Özyar E
Brachytherapy; 2024; 23(1):18-24. PubMed ID: 38000958
[TBL] [Abstract][Full Text] [Related]
5. Radiobiological optimization comparison between pulse-dose-rate and high-dose-rate brachytherapy in patients with locally advanced cervical cancer.
Annede P; Dumas I; Schernberg A; Tailleur A; Fumagalli I; Bockel S; Mignot F; Kissel M; Deutsch E; Haie-Meder C; Chargari C
Brachytherapy; 2019; 18(3):370-377. PubMed ID: 30797698
[TBL] [Abstract][Full Text] [Related]
6. Dosimetric and radiobiological comparison of treatment plan between CyberKnife and EDGE in stereotactic body radiotherapy for pancreatic cancer.
Dai ZT; Ma L; Cao TT; Zhu L; Zhao M; Li N
Sci Rep; 2021 Feb; 11(1):4065. PubMed ID: 33603030
[TBL] [Abstract][Full Text] [Related]
7. Radiobiological and dosimetric comparison of 60Co versus 192Ir high-dose-rate intracavitary-interstitial brachytherapy for cervical cancer.
Wen A; Wang X; Wang B; Yan C; Luo J; Wang P; Li J
Radiat Oncol; 2022 Dec; 17(1):206. PubMed ID: 36514118
[TBL] [Abstract][Full Text] [Related]
8. Dosimetry analyses comparing high-dose-rate brachytherapy, administered as monotherapy for localized prostate cancer, with stereotactic body radiation therapy simulated using CyberKnife.
Fukuda S; Seo Y; Shiomi H; Yamada Y; Ogata T; Morimoto M; Konishi K; Yoshioka Y; Ogawa K
J Radiat Res; 2014 Nov; 55(6):1114-21. PubMed ID: 24957754
[TBL] [Abstract][Full Text] [Related]
9. Optimized stereotactic volumetric modulated arc therapy as an alternative to brachytherapy for vaginal cuff boost. A dosimetric study.
Cilla S; Macchia G; Mattiucci G; Ianiro A; Romano C; Buwenge M; Azario L; Valentini V; Deodato F; Morganti AG
Med Dosim; 2020 Winter; 45(4):352-358. PubMed ID: 32565068
[TBL] [Abstract][Full Text] [Related]
10. Brachytherapy Versus Stereotactic Body Radiotherapy for Cervical Cancer Boost: A Dosimetric Comparison.
Dahbi Z; Fadila K; Vinh-Hung V
Cureus; 2023 Apr; 15(4):e37235. PubMed ID: 37038382
[TBL] [Abstract][Full Text] [Related]
11. Intracavitary/Interstitial Applicator Plus Distal Parametrial Free Needle Interstitial Brachytherapy in Locally Advanced Cervical Cancer: A Dosimetric Study.
Qu HD; Han DM; Zhang N; Mao Z; Cheng GH
Front Oncol; 2020; 10():621347. PubMed ID: 33680943
[TBL] [Abstract][Full Text] [Related]
12. Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer.
Assenholt MS; Vestergaard A; Kallehauge JF; Mohamed S; Nielsen SK; Petersen JB; Fokdal L; Lindegaard JC; Tanderup K
Brachytherapy; 2014; 13(4):361-8. PubMed ID: 24656732
[TBL] [Abstract][Full Text] [Related]
13. A dosimetric comparison of Volumetric Modulated Arc Therapy (VMAT) and High Dose Rate (HDR) brachytherapy in localized cervical cancer radiotherapy.
Wali L; Helal A; Darwesh R; Attar M
J Xray Sci Technol; 2019; 27(3):473-483. PubMed ID: 30958322
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of High Risk Clinical Target Volume reduction during Brachytherapy and impact on its coverage in patients with inoperable cervical cancer.
Pobijakova M; Scepanovic D; Paluga M; Fekete M; Mardiak J
Neoplasma; 2018 Mar; 65(3):425-430. PubMed ID: 29788726
[TBL] [Abstract][Full Text] [Related]
15. Analysis of clinical utilization of ring applicator for combined intracavitary/interstitial image-guided brachytherapy treatment in Chinese patients with locally advanced cervical cancer.
Zhao Z; Zhang N; Liu Y; Wu N; Mao Z; Yang W; Cheng G
J Contemp Brachytherapy; 2020 Jun; 12(3):252-259. PubMed ID: 32695197
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric comparison of MRI-based HDR brachytherapy and stereotactic radiotherapy in patients with advanced cervical cancer: A virtual brachytherapy study.
Otahal B; Dolezel M; Cvek J; Simetka O; Klat J; Knybel L; Molenda L; Skacelikova E; Hlavka A; Feltl D
Rep Pract Oncol Radiother; 2014 Nov; 19(6):399-404. PubMed ID: 25337413
[TBL] [Abstract][Full Text] [Related]
17. Is a clinical target volume (CTV) necessary for locally advanced non-small cell lung cancer treated with intensity-modulated radiotherapy? -a dosimetric evaluation of three different treatment plans.
Xia F; Zhou L; Yang X; Chu L; Zhang X; Chu J; Hu W; Zhu Z
J Thorac Dis; 2017 Dec; 9(12):5194-5202. PubMed ID: 29312726
[TBL] [Abstract][Full Text] [Related]
18. A dose planning study on applicator guided stereotactic IMRT boost in combination with 3D MRI based brachytherapy in locally advanced cervical cancer.
Assenholt MS; Petersen JB; Nielsen SK; Lindegaard JC; Tanderup K
Acta Oncol; 2008; 47(7):1337-43. PubMed ID: 18663651
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric comparison between stereotactic body radiotherapy and carbon-ion radiation therapy for prostate cancer.
Huang HF; Gao XX; Li Q; Ma XY; Du LN; Sun PF; Li S
Quant Imaging Med Surg; 2023 Oct; 13(10):6965-6978. PubMed ID: 37869307
[TBL] [Abstract][Full Text] [Related]
20. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
